Erratum to: Aminochrome Induces Disruption of Actin, Alpha-, and Beta-Tubulin Cytoskeleton Networks in Substantia-Nigra-Derived Cell Line (Neurotoxicity Research DOI: 10.1007/s12640-009-9148-4);Aminochrome induces disruption of actin, alpha-, and beta-tubulin cytoskeleton networks in substantia-nigra-derived cell line

Neurotoxicity Research

Volumn 18, Issue 1, 2010, Pages 82-92

  Paris, Irmgard ^a,c   Perez Pastene, Carolina ^a   Cardenas, Sergio ^a   Iturra, Patricio ^b   Muñoz, Patricia ^a   Couve, Eduardo ^d   Caviedes, Pablo ^a   Segura Aguilar, Juan ^a  

^a UNIVERSITY OF CHILE   (Chile)

^b UNIVERSITY OF CHILE   (Chile)

^c UNIVERSIDAD SANTO TOMÁS   (Chile)

^d UNIVERSIDAD DE VALPARAÍSO   (Chile)

Author keywords

Actin; Aminochrome; Cell shrinkage; Cytoskeleton; Dopamine; DT diaphorase; Tubulin

Indexed keywords

ACTIN; AMINOCHROME 1; INDOLE DERIVATIVE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE); TUBULIN;

ANIMAL; ARTICLE; CELL LINE; CHEMISTRY; CONFOCAL MICROSCOPY; CYTOLOGY; DRUG EFFECT; METABOLISM; METHODOLOGY; NUCLEAR MAGNETIC RESONANCE; RAT; SUBSTANTIA NIGRA; TRANSMISSION ELECTRON MICROSCOPY; ULTRASTRUCTURE;

ACTINS; ANIMALS; CELL LINE, TRANSFORMED; INDOLEQUINONES; MICROSCOPY, CONFOCAL; MICROSCOPY, ELECTRON, TRANSMISSION; NAD(P)H DEHYDROGENASE (QUINONE); NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; RATS; SUBSTANTIA NIGRA; TUBULIN;

EID: 77956083797     PISSN: 10298428     EISSN: 14763524     Source Type: Journal    
DOI: 10.1007/s12640-010-9151-9     Document Type: Erratum

References (52)

1. Arriagada A, Paris I, Sanchez de las Matas MJ, Martinez-Alvarado P, Cardenas S, Castañeda P, Graumann R, Perez-Pastene C, Olea-Azar C, Couve E, Herrero MT, Caviedes P, Segura-Aguilar J (2004) On the neurotoxicity of leukoaminochrome o-semiquinone radical derived of dopamine oxidation: mitochondria damage, necrosis and hydroxyl radical formation. Neurobiol Dis 16:468-477 (Pubitemid 38757327)
2. Baez S, Linderson Y, Segura-Aguilar J (1995) Superoxide dismutase and catalase enhance autoxidation during one-electron reduction of aminochrome by NADPH-cytochrome P-450 reductase. Biochem Mol Med 54:12-18
3. Bisaglia M, Mammi S, Bubacco L (2007) Kinetic and structural analysis of the early oxidation products of dopamine: analysis of the interactions with alpha-synuclein. J Biol Chem 282:15597-155605
4. Büchi G, Kamikawa T (1977) An alternate synthesis of 5, 6-dihydroxy-2, 3-dihydroindole-2-carboxylates (cyclodopa). J Org Chem 42:4153-4154 (Pubitemid 8276198)
5. Buchman VL, Ninkina N (2008a) Modulation of alpha-synuclein expression in transgenic animals for modelling synucleinopathies-is the juice worth the squeeze? Neurotox Res 14:329-341
6. Buchman VL, Ninkina N (2008b) Mouse models for studying function of synuclein family members in the normal and degenerating brain. Neurotox Res 13:121
7. Cardenas S, Paris I, Fuentes-Bravo P, Graumann R, Riveros A, lozano J, Calegaro M, Caviedes P, Segura-Aguilar J (2008a) DTdiaphorase protection in catecholaminergic cell line against aminochrome neurotoxic effects. Neurotox Res 13:120
8. Cardenas SP, Perez-Pastene C, Couve E, Segura-Aguilar J (2008b) The DT-diaphorase prevents the aggregation of a-synuclein induced by aminochrome. Neurotox Res 13:136
9. Cingolani LA, Goda Y (2008) Actin in action: the interplay between the actin cytoskeleton and synaptic efficacy. Nat Rev Neurosci 9:344-356 (Pubitemid 351556045)
10. Conway KA, Lee SJ, Rochet JC, Ding TT, Williamson RE, Lansbury PT Jr (2000) Acceleration of oligomerization, not fibrillization, is a shared property of both alpha-synuclein mutations linked to early-onset Parkinson's disease: implications for pathogenesis and therapy. Proc Natl Acad Sci USA 97:571-576 (Pubitemid 30070350)
11. Conway KA, Rochet JC, Bieganski RM, Lansbury PT Jr (2001) Kinetic stabilization of the alpha-synuclein protofibril by a dopamine-alpha-synuclein adduct. Science 294:1346-1349 (Pubitemid 33063102)
12. Diaz-Corrales FJ, Asanuma M, Miyazaki I, Miyoshi K, Hattori N, Ogawa N (2008) Dopamine induces supernumerary centrosomes and subsequent cell death through Cdk2 up-regulation in dopaminergic neuronal cells. Neurotox Res 14:295-305
13. Dillon C, Goda Y (2005) The actin cytoskeleton: integrating form and function at the synapse. Annu Rev Neurosci 28:25-55 (Pubitemid 41098898)
14. Duka T, Sidhu A (2006) The neurotoxin, MPP+, induces hyperphosphorylation of Tau, in the presence of alpha-Synuclein, in SH-SY5Y neuroblastoma cells. Neurotox Res 10:1-10
15. Fernández CO (2008) Synucleinnopathies: structural features and molecular interactions. Neurotox Res 13:120
16. Fuentes P, Paris I, Nassif M, Caviedes P, Segura-Aguilar J (2007) Inhibition of VMAT-2 and DT-Diaphorase induce cell death in a substantia nigra-derived cell line-an experimental cell model for dopamine toxicity studies. Chem Res Toxicol 20:776-783 (Pubitemid 46953684)
17. Gácsi M, Antal O, Vasas G, Máthé C, Borbély G, Saker ML, Gyori J, Farkas A, Vehovszky A, Bánfalvi G (2009) Comparative study of cyanotoxins affecting cytoskeletal and chromatin structures in CHO-K1 cells. Toxicol In Vitro 23:710-718
18. Gzauthier MA, Eibl JK, Crispo JA, Ross GM (2008) Covalent arylation of metallothionein by oxidized dopamine products: a possible mechanism for zinc-mediated enhancement of dopaminergic neuron survival. Neurotox Res 14:317-328
19. González-Aragón D, Ariza J, Villalba JM (2007) Dicoumarol impairs mitochondrial electron transport and pyrimidine biosynthesis in human myeloid leukemia HL-60 cells. Biochem Pharmacol 73: 427-439 (Pubitemid 44970449)
20. Hastings TG (1995) Enzymatic oxidation of dopamine: the role of prostaglandin H synthase. J Neurochem 64:919-924
21. Hirokawa N, Sobue K, Kanda K, Harada A, Yorifuji H (1989) The cytoskeletal architecture of the presynaptic terminal and molecular structure of synapsin. J Cell Biol 108:111-126 (Pubitemid 19050606)
22. Krasnova IN, Betts ES, Dada A, Jefferson A, Ladenheim B, Becker KG, Cadet JL, Hohmann CF (2007) Neonatal dopamine depletion induces changes in morphogenesis and gene expression in the developing cortex. Neurotox Res 11:107-130
23. Kueh HY, Mitchison TJ (2009) Structural plasticity in actin and tubulin polymer dynamics. Science 325:960-963
24. Letourneau PC (2009) Actin in axons: stable scaffolds and dynamic filaments. Results Probl Cell Differ 48:65-90
25. Liberato D, Byers V, Dennick R, Castagnoli N (1981) Regiospecific attack of nitrogen and sulfur nucleophiles on quinones derived from poison oak/ivy catechols (urushiols) and analogs as models for urushiol-protein conjugate formation. J Med Chem 24:28-33 (Pubitemid 11189897)
26. Ligon LA, Steward O (2000) Role of microtubules and actin filaments in the movement of mitochondria in the axons and dendrites of cultured hippocampal neurons. J Comp Neurol 427:351-361
27. Morris RL, Hollenbeck PJ (1995) Axonal transport of mitochondria along microtubules and F-actin in living vertebrate neurons. J Cell Biol 131:1315-1326
28. Norris EH, Giasson BI, Hodara R, Xu S, Trojanowski JQ, Ischiropoulos H, Lee VM (2005) Reversible inhibition of alpha-synuclein fibrillization by dopaminochrome - mediated conformational alterations. J Biol Chem 280:21212-21219 (Pubitemid 40805683)
29. Papakonstanti EV, Vardaki EA, Stournaras C (2000) Actin cytoskeleton: a signaling sensor in cell volume regulation. Cell Physiol Biochem 10:257-264 (Pubitemid 32010734)
30. Paris I, Dagnino-Subiabre A, Marcelain K, Bennett LB, Caviedes P, Caviedes R, Olea-Azar C, Segura-Aguilar J (2001) Copper neurotoxicity is dependent on dopamine-mediated copper uptake and one-electron reduction of aminochrome in a rat substantia nigra neuronal cell line. J Neurochem 77:519-529 (Pubitemid 32298746)
31. Paris I, Martinez-Alvarado P, Cardenas S, Perez-Pastene C, Graumann R, Fuentes P, Olea-Azar C, Caviedes P, Segura-Aguilar J (2005a) Dopamine-dependent iron toxicity in cells derived from rat hypothalamus. Chem Res Toxicol 18:415-419 (Pubitemid 40393163)
32. Paris I, Martinez-Alvarado P, Perez-Pastene C, Vieira MN, Olea-Azar C, Raisman-Vozari R, Cardenas S, Graumann R, Caviedes P, Segura-Aguilar J (2005b) Monoamine transporter inhibitors and norepinephrine reduce dopamine-dependent iron toxicity in cells derived from the substantia nigra. J Neurochem 92:1021-1032 (Pubitemid 40344293)
33. Paris I, Cardenas S, Perez-Pastene C, Lozano J, Graumann R, Riveros A, Caviedes P, Segura-Aguilar J (2007) Aminochrome as preclinical model to study degeneration of dopaminergic neurons in Parkinson's disease. Neurotox Res 12:125-134
34. Paris I, Lozano J, Cardenas S, Perez-Pastene C, Saud K, Fuentes P, Caviedes P, Dagnino-Subiabre A, Raisman-Vozari R, Shimahara T, Kostrzewa JP, Chi D, Kostrzewa RM, Caviedes P, Segura-Aguilar J (2008a) The catecholaminergic RCSN-3 cell line: a model to study dopamine metabolism. Neurotox Res 13:221-230
35. Paris I, Mora S, Raisman-Vozari R, Segura-Aguilar J (2008b) Copper neurotoxicity in rat substantia nigra and striatum is dependent on DT-diaphorase inhibition. Chem Res Toxicol 21:1180-1185 (Pubitemid 351967381)
36. Paris I, Lozano J, Perez-Pastene C, Muñoz P, Segura-Aguilar J (2009a) Molecular and neurochemical mechanisms in PD pathogenesis. Neurotox Res 16:271-279
37. Paris I, Perez-Pastene C, Couve E, Caviedes P, Ledoux S, Segura-Aguilar J (2009b) Copper dopamine complex induces mitochondrial autophagy preceding caspase-independent apoptotic cell death. J Biol Chem 284:13306-13315
38. Polymeropoulos MH, Lavedan C, Leroy E, Ide SE, Dehejia A, Dutra A, Pike B, Root H, Rubenstein J, Boyer R, Stenroos ES, Chandrasekharappa S, Athanassiadou A, Papapetropoulos T, Johnson WG, Lazzarini AM, Duvoisin RC, Di Iorio G, Golbe LI, Nussbaum RL (1997) Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science 276: 2045-2047 (Pubitemid 27443610)
39. Riveros A, Cuchillo I, Hanger D, Segura-Aguilar J, Stephenson J (2008) Studies on the effect of the aminochrome treatment in the axonal transport of alpha-synuclein. Neurotox Res 13:147
40. Schultzberg M, Segura-Aguilar J, Lind C (1988) Distribution of DT-diaphorase in the rat brain: biochemical and immunohistochemical studies. Neuroscience 27:763-766
41. 3+ induced neurotoxicity of dopamine: prevention of quinone derived oxygen toxicity by DT-diaphorase and superoxide dismutase. Chem Biol Interact 72:309-324
42. Segura-Aguilar J, Baez S, Widersten M, Welch CJ, Mannervik B (1997) Human class Mu glutathione transferases, in particular isoenzyme M2-2, catalyze detoxication of the dopamine metabolite aminochrome. J Biol Chem 272:5727-5731 (Pubitemid 27102401)
43. Segura-Aguilar J, Metodiewa D, Welch C (1998) Metabolic activation of dopamine o-quinones to o-semiquinones by NADPH cytochrome P450 reductase may play an important role in oxidative stress and apoptotic effects. Biochim Biophys Acta 1381:1-6
44. 3+ to produce a 6-OH-dopamine like rotational behaviour. NeurotoxRes 4:127-131
45. Segura-Aguilar J, Cardenas S, Riveros A, Fuentes-Bravo P, Lozano J, Graumann R, Paris I, Nassif M, Caviedes P (2006) DTdiaphorase prevents the formation of alpha-synuclein adducts with aminochrome. Soc Neurosci Abstr 824:17
46. Sulzer D, Talloczy Z, Mosharov EM, Martinez-Vicente M, Cuervo AM (2008) Alphasynuclein and autophagy as an early step in Parkinson's disease. Neurotox Res 13:120
47. Van Laar VS, Mishizen AJ, Cascio M, Hastings TG (2009) Proteomic identification of dopamine-conjugated proteins from isolated rat brainmitochondria and SH-SY5Y cells. Neurobiol Dis 34:487-500
48. Wersinger C, Sidhu A (2005) Disruption of the interaction of Rsynuclein with microtubules enhances cell surface recruitment of the dopamine transporter. Biochemistry 44:13612-13624 (Pubitemid 41443689)
49. Wolff J (2009) Plasma membrane tubulin. Biochim Biophys Acta 1788:1415-1433
50. Zecca L, Fariello R, Riederer P, Sulzer D, Gatti A, Tampellini D (2002) The absolute concentration of nigral neuromelanin, assayed by a new sensitive method, increases throughout the life and is dramatically decreased in Parkinson's disease. FEBS Lett 510:216-220 (Pubitemid 34093828)
51. Zecca L, Bellei C, Costi P, Albertini A, Monzani E, Casella L, Gallorini M, Bergamaschi L, Moscatelli A, Turro NJ, Eisner M, Crippa PR, Ito S, Wakamatsu K, Bush WD, Ward WC, Simon JD, Zucca FA (2008) New melanic pigments in the human brain that accumulate in aging and block environmental toxic metals. Proc Natl Acad Sci USA 105:17567-17572
52. Zoccarato F, Toscano P, Alexandre A (2005) Dopamine-derived dopaminochrome promotes H(2)O(2) release at mitochondrial complex I: stimulation by rotenone, control by Ca(2+), and relevance to Parkinson disease. J Biol Chem 280:15587-15594 (Pubitemid 40616675)